Nick Mordwinkin
Corporate Officer/Principal presso KEZAR LIFE SCIENCES, INC.
Patrimonio netto: - $ in data 30/04/2024
Profilo
Nick Mordwinkin was the founder of Curium, a company founded in 2014, where he held the title of President from 2014 to 2016.
He is currently the Chief Business Officer at Kezar Life Sciences, Inc. since 2022.
Previously, he worked at Ultragenyx Pharmaceutical, Inc. from 2015 to 2020 as the Senior Director & Head-Corporate Strategy.
From 2020 to 2022, he was the Head-Development, Inflammation & Fibrosis at Gilead Sciences, Inc. Dr. Mordwinkin holds a doctorate degree from the University of Southern California and an undergraduate degree from Nova Southeastern University, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
KEZAR LIFE SCIENCES INC
-.--% | 01/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Nick Mordwinkin
| Società | Posizione | Inizio |
|---|---|---|
| KEZAR LIFE SCIENCES, INC. | Corporate Officer/Principal | 11/07/2022 |
Precedenti posizioni note di Nick Mordwinkin
| Società | Posizione | Fine |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/06/2022 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/10/2020 |
| Curium | Fondatore | 01/12/2016 |
Formazione di Nick Mordwinkin
| University of Southern California | Doctorate Degree |
| Nova Southeastern University, Inc. | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
| Curium |
- Borsa valori
- Insiders
- Nick Mordwinkin